Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
bioMerieux
bioMerieux
Activities:
Regulatory
Analysis
X
LinkedIn
Trending Articles
OINDPs: Nosey about recent developments?
OINDPs are a user friendly and efficacious alternative to injectables in several disease areas
Transforming healthcare with patient centricity
In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Compact process thermostat for efficient temperature control in the laboratory
The temperature control system is designed for the accurate temperature control of small research reactors between -40 to +200 °C
AviadoBio expands presence at Canary Wharf
The company has acquired 11,000 sqft of laboratory and office space in Canary Wharf to accommodate the growing team
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Regulatory
bioMérieux and JMI Laboratories partner to fight antimicrobial resistance
JMI Laboratories is a recent member of the Element Group, a leading global Testing, Inspection and Certification (TIC) company, through acquisition in November 2021
Drug Delivery
InDevR raises $9m in series B financing
ioMérieux will also become the exclusive distributor of the VaxArray portfolio in Europe
Regulatory
bioMérieux receives FDA clearance for mass spectrometry ID system
With 1.3 million deaths worldwide annually, antimicrobial resistance (AMR) is a global health priority
Manufacturing
Recombinant Factor C assay to aid demand for LAL endotoxin testing
Kevin Williams from bioMerieux discusses the recombinant Factor C assay that has been developed to help alleviate the pressures of a growing demand for the Limulus amoebocyte lysate assay
Analysis
bioMérieux launches automated diagnostic solution for microbial detection
EviSight Compact provides reliable results for increased product safety and reduces costs for pharmaceutical companies
Finance
BioMérieux acquires Hyglos for a total consideration of €24m
Expands its offering for the detection of endotoxins in pharmaceutical products
Analysis
Revolutionised and Robust: Environmental Identification Webinar - mid-October
Environmental identification, including moulds, by MALDI-TOF Mass Spectrometry
Subscribe now